Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125

• मुख्य लेखकों: Szu-Ting Yang (लेखक), Wen-Hsun Chang (लेखक), Fang-Wei Chou (लेखक), Hung-Hsien Liu (लेखक), Wen-Ling Lee (लेखक), Peng-Hui Wang (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2023-11-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

The current standard therapy of epithelial ovarian cancer (EOC) is the combination of surgery (primary cytoreductive surgery or interval cytoreductive surgery) and platinum-based chemotherapy (mainly using paclitaxel and carboplatin either by neoadjuvant chemotherapy and/or by postoperative adjuvant...